HS headings: 30, 2941
Tablets, capsules, oral liquids and injectables from WHO-GMP plants, sourced against the buyer's registered dossier.
Pharmacopoeial-grade APIs and intermediates with DMF/CEP support from Indian bulk-drug plants.